{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-029939","form_type":"8-K","ticker":"BTCY","cik":"0001630113","company_name":"BIOTRICITY INC.","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.867890+00:00","generated_at":"2026-05-31T13:50:55.709831+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biotricity receives Nasdaq bid price deficiency notice; 180-day cure period to Jan 22, 2025","bullets":["Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq Listing Rule 5550(a)(2) deficiency.","Company has until January 22, 2025 to regain compliance with minimum $1.00 closing bid for 10 consecutive days.","If non-compliant by Jan 22, may receive additional 180-day period to cure, subject to other listing standards.","Biotricity intends to monitor bid price and consider available options, including a reverse stock split.","No immediate impact on Nasdaq listing or trading of BTCY common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-029939","json":"https://secwatch.observer/filing/0001493152-24-029939.json","markdown":"https://secwatch.observer/filing/0001493152-24-029939.md","text":"https://secwatch.observer/filing/0001493152-24-029939.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/0001493152-24-029939-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:50:55.709831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}